pindolol has been researched along with Dermatitis Medicamentosa in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In our study, we demonstrated that transdermal application of a beta-blocker (20 mg mepindolol) in patients with essential hypertension led to effective blood pressure lowering effect within 1 week (160." | 3.67 | Transdermal beta-blocker therapy in essential hypertension. ( Liedtke, R; Spieker, C; Vetter, H; Vetter, W; Zidek, W, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palatsi, R | 1 |
| Spieker, C | 1 |
| Vetter, H | 1 |
| Liedtke, R | 1 |
| Zidek, W | 1 |
| Vetter, W | 1 |
2 other studies available for pindolol and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A skin reaction to pindololum, a beta-blocking drug.
Topics: Drug Eruptions; Humans; Male; Middle Aged; Pindolol; Skin | 1976 |
Transdermal beta-blocker therapy in essential hypertension.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Blood Pressure; Drug Eruptions; Femal | 1988 |